Stoneham, MA, United States of America

Christopher G Nasveschuk

This inventor holds 66 USPTO granted patents and 24 published patent applications, plus 1 CIPO patent and 24 EPO patents, primarily in Targeted Protein Degradation. Top assignees: C4 Therapeutics, Inc., Constellation Pharmaceuticals, Inc., Genentech, Inc.. Active years: 2014-2026.

USPTO Granted Patents = 66 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.5

ph-index = 9

Forward Citations = 265(Granted Patents)

Forward Citations (Not Self Cited) = 130(Dec 10, 2025)


Location History:

  • Stoneham, MA (US) (2014 - 2024)
  • Cambridge, MA (US) (2018 - 2024)
  • Syoneham, MA (US) (2024)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
C3-Carbon Linked Glutarimide
Degronimers
BRAF Degraders
Heterocyclic Compounds
Isoindolinone
Indazole Compounds
Therapeutics
Cereblon Binders
Spirocyclic Compounds
Macrocyclic Derivatives
BRD9 Degradation
N/O-Linked Degrons
66 patents (USPTO):Explore Patents

Title: The Inventor Christopher G Nasveschuk

Introduction: Christopher G Nasveschuk is a renowned inventor based in Stoneham, MA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Christopher G Nasveschuk holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Christopher G Nasveschuk has established himself as a prolific inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them.

Collaborations: Throughout his career, Christopher G Nasveschuk has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Christopher G Nasveschuk's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor whose impact will be felt for years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…